Jixiang Zhang - Publications

Affiliations: 
2022- Symptom Research University of Texas M.D. Anderson Cancer Center 

3 high-probability publications. We are testing a new system for linking publications to authors. You can help! If you notice any inaccuracies, please sign in and mark papers as correct or incorrect matches. If you identify any major omissions or other inaccuracies in the publication list, please let us know.

Year Citation  Score
2023 Yap TA, Daver N, Mahendra M, Zhang J, Kamiya-Matsuoka C, Meric-Bernstam F, Kantarjian HM, Ravandi F, Collins ME, Francesco MED, Dumbrava EE, Fu S, Gao S, Gay JP, Gera S, et al. Complex I inhibitor of oxidative phosphorylation in advanced solid tumors and acute myeloid leukemia: phase I trials. Nature Medicine. PMID 36658425 DOI: 10.1038/s41591-022-02103-8  0.39
2022 Zhang J, Junigan JM, Trinh R, Kavelaars A, Heijnen CJ, Grace PM. HDAC6 inhibition reverses cisplatin-induced mechanical hypersensitivity via tonic delta opioid receptor signaling. The Journal of Neuroscience : the Official Journal of the Society For Neuroscience. PMID 36096670 DOI: 10.1523/JNEUROSCI.1182-22.2022  0.429
2015 Li J, Zhang J, Zhang N, Zhang Y, Wu W, Li J. Development of a replicative plasmid for gene expression in Mycoplasma bovis. Journal of Microbiological Methods. 108: 12-8. PMID 25451459 DOI: 10.1016/j.mimet.2014.11.005  0.404
Show low-probability matches.